The Washington Early Recognition Center specializes in youth psychosis
Faculty members honored for ‘highly prolific spirit of innovation’
16-question tool designed to identify young people at high risk
WashU receives part of $103 million to address depression, anxiety related to pandemic
Teens, young adults needed for study aimed at improving early diagnosis
Low-cost drug lowers risk of hospitalizations, deaths
Research to explore the effects of social isolation on cognitive, emotional health
Complements efforts of Taylor Family Institute to develop treatments for psychiatric illness
Researchers to study ways to improve mental health for surgery patients
Dr. Daniel Mamah was announced as this year’s recipient of the 2021 Dr. John M. Anderson Excellence in Mental Health Award. The St. Louis County Children’s Service Fund honors a mental healthcare professional each year who has made significant contributions in the field of behavioral health. Dr. John M. Anderson was an African American psychiatrist […]
Researchers at Washington University School of Medicine in St. Louis and the University of Chicago have found that a single, one-hour treatment that involves breathing in a mixture of oxygen and the anesthetic drug nitrous oxide — otherwise known as laughing gas — can significantly improve symptoms in people with treatment-resistant depression.
Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19
Antidepressant drug repurposed for patients with coronavirus infection
Fear of contracting or spreading COVID-19 might be increasing the severity of these symptoms, notes Dr. Cynthia Rogers.
The Food and Drug Administration has approved a variant of the anesthetic and party drug ketamine for suicidal patients with major depression.
Joan Luby, MD, director of the School of Medicine’s Early Emotional Development Program and the Samuel and Mae S. Ludwig Professor of Child Psychiatry, will receive the Carl and Gerty Cori Faculty Achievement Award. Douglas F. Covey, the Andrew C. and Barbara B. Taylor Distinguished Professor of Psychiatry at the School of Medicine, will receive […]
Washington University in St. Louis will begin construction in March on what will be one of the largest neuroscience research buildings in the country.
Professorship supports research in new treatment strategies for psychiatric illness
Glowinski, artist Outlaw address mental health through artwork.
Adam Kepecs, PhD, recognized internationally for his research on neural circuits responsible for cognition and decision-making, has been named a BJC Investigator and a professor of neuroscience and psychiatry at Washington University School of Medicine in St. Louis.
Philanthropists Andrew and Barbara Taylor and the Crawford Taylor Foundation have committed $10 million to Washington University School of Medicine in St. Louis to continue research to investigate the scientific underpinnings of psychiatric illnesses, with the goal of improving diagnosis and treatment.
Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research from Washington University in St. Louis has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.
A biomedical engineer at Washington University in St. Louis is developing a therapeutic option that would prevent the opiates from crossing the blood-brain barrier, preventing the high abusers seek.
The first drug for women suffering postpartum depression received federal approval on Tuesday, a move likely to pave the way for a wave of treatments to address a debilitating condition that is the most common complication of pregnancy.
A research team led by Washington University School of Medicine in St. Louis has received a five-year, $3.8 million grant to evaluate the use of smartphones in treating psychiatric problems that are common among college students.
Washington University School of Medicine colleagues Rupa Patel, MD, and Anne Glowinski, MD, are working with an organization in Bangladesh to help deliver mental health care to Rohingya refugees from Myanmar.
Study refutes idea that children who talk about suicide don’t understand it
Seven years ago, Chancellor Mark S. Wrighton (left) asked Andrew C. Taylor, executive chairman of Enterprise Holdings and a life trustee of the university, to chair the public phase of Leading Together.
Also Known As: δ* KI δ* KI is a CRISPR/cas9-made knock-in allele with a T269Y mutation in Gabrd exon 8 that renders δ-containing receptor populations insensitive to picrotoxin (PTX). These mice allow chemogenetic isolation of δ-containing GABAA receptors, and may be useful for neurological studies of receptor, ion channel and synapse biology, neurotransmitters, and glutamate/GABA transmission.
Key alcoholism gene influences how quickly body metabolizes alcohol
Brain changes evident in scans before memory, cognitive decline
In 2012, Andrew and Barbara Taylor and the Crawford Taylor Foundation pledged $20 million to the Department of Psychiatry at Washington University’s School of Medicine to establish a research institute dedicated to advancing new treatments for mental illnesses. Just six years later, investigators in the department’s Taylor Family Institute for Innovative Psychiatric Research are on […]
A $10 million commitment from Andrew Taylor, a life trustee at Washington University in St. Louis, and his wife, Barbara, will establish the Taylor Family Scholarship Challenge, which will match all new and increased gifts for undergraduate scholarships received by the conclusion of Leading Together: The Campaign for Washington University on June 30, 2018, as well as […]
Grant to renew annual clinic, advance understanding of rare disorder
We are so excited to have Meaghan Creed and Lex Kravitz headed to St. Louis to join the Washington University School of Medicine research community.